Video: Potential AIDS vaccine targets blood, mucosal tissue

November 27, 2013

December 1st is the annual World AIDS Day, a perfect opportunity to look at how medical research is progressing to fight the disease.

HIV is still plaguing humanity with 35 million infected people worldwide. Antiretroviral drugs do slow down the progression of the disease, but at a high cost and with long-term toxicity. More than ever, the need for a vaccine is urgent.

A current European research project seeks to block the entry of HIV into cells at mucosal sites and in the blood. Why target mucosal sites? Because 90% of HIV infections happen via the sexual route. Obtaining an immune response at this gateway could therefore mean efficiently blocking the virus and prevent it from ever entering the body.

The video will load shortly

A first clinical trial on humans has just finished to check for toxicity. In the next step, researchers will determine whether the blood and mucosal tissue of the volunteers produces the neutralizing antibodies after exposure to HIV in the lab.

Explore further: Texas Biomed files patent for a novel HIV vaccine strategy

Related Stories

Texas Biomed files patent for a novel HIV vaccine strategy

November 19, 2012

The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites ...

Newly discovered breast milk antibodies help neutralize HIV

May 22, 2012

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

New target to fight HIV infection identified

October 1, 2013

A mutant of an immune cell protein called ADAP (adhesion and degranulation-promoting adaptor protein) is able to block infection by HIV-1 (human immunodeficiency virus 1), new University of Cambridge research reveals. The ...

Monoclonal antibodies show promise as effective HIV therapy

October 30, 2013

A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. Published on-line ...

Recommended for you

S.Africa launches major new trial of AIDS vaccine

November 29, 2016

South Africa on Wednesday launched a major clinical trial of an experimental vaccine against the AIDS virus, which scientists hope could be the "final nail in the coffin" for the disease.

HIV survives in our chromosomal DNA

November 17, 2016

It has been said that HIV cannot be cured since the virus propagates in places beyond the reach of antiviral agents. New research from Karolinska Institutet suggests, however, that this view is incorrect.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.